Catherine Martin

Catherine Martin, MD is a Professor of Psychiatry at the University of Kentucky College of Medicine, with additional affiliations as a Member of the Cancer Prevention and Control Research Program and the Markey Cancer Center/Cancer Research Priority Initiative. Her academic career spans over four decades since earning her medical degree from the University of Kentucky in 1976.

Dr. Martin's educational background includes a Bachelor of Science (1972), Doctor of Medicine (1976), and Residencies (1978, 1980), all from the University of Kentucky. Her training established the foundation for her extensive research career in psychiatric and substance abuse disorders.

Dr. Martin's research focuses on substance abuse neuroscience, with particular expertise in amphetamine effects, ADHD, adolescent mental health, and tobacco cessation. Her work investigates individual differences in drug effects, changes in sex steroids, and novel therapies for smoking cessation including pharmacotherapies and behavioral interventions. She has made significant contributions to understanding the relationship between adverse childhood experiences and substance use disorders.

Analysis of her recent publications reveals consistent focus on substance abuse, particularly tobacco and amphetamines, with strong emphasis on adolescent populations. Her work bridges neuroscience, clinical psychiatry, and public health, frequently examining the intersection of mental illness and substance use disorders. She employs diverse methodologies including neuroimaging, behavioral pharmacology, and systematic reviews.

Dr. Martin has secured substantial research funding from major organizations including the National Institute on Drug Abuse and National Institute of Mental Health. Her projects address critical issues such as opioid use disorder treatment, ADHD and cognition, tobacco regulatory science, and physician training in substance abuse.

She actively collaborates with researchers across multiple institutions, with notable work on projects examining mindfulness in childhood trauma survivors, estrogen effects on ADHD, and Appalachian tobacco regulatory science. Her research team includes experts in statistics, behavioral interventions, and clinical psychiatry.